KILITCH

Kilitch Drugs(I) Share PriceKilitch Drugs(I)

₹140.00
-0.2 (-0.14%)
As on 31 March, 2023 | 21:34 BSE: 524500 NSE: KILITCH

Kilitch Drugs(I) Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Kilitch Drugs(I)

Start SIP

Kilitch Drugs(I) Share Price

  • Over 1 Month -1.16%
  • Over 3 Month -10.05%
  • Over 6 Month -15.15%
  • Over 1 Year -16.34%

Kilitch Drugs(I) Key Statistics

P/E Ratio 22.3
PEG Ratio 0.3
Market Cap Cr 218
Price to Book Ratio 1.6
EPS 5.9
Dividend 0
Relative Strength Index 45.69
Money Flow Index 75.27
MACD Signal 0.58
Average True Range 10.31

Kilitch Drugs(I) Investment Rating

  • Master Rating:
  • Kilitch Drugs India has an operating revenue of Rs. 130.73 Cr. on a trailing 12-month basis. An annual revenue growth of 65% is outstanding, Pre-tax margin of 8% is okay, ROE of 5% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 59 which is a POOR score indicating inconsistency in earnings, a RS Rating of 40 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 87 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Kilitch Drugs(I) Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 29222432
Operating Expenses Qtr Cr 24192028
Operating Profit Qtr Cr 4334
Depreciation Qtr Cr 0000
Interest Qtr Cr 0000
Tax Qtr Cr 1011
Net Profit Qtr Cr 4433

Kilitch Drugs(I) Technicals

EMA & SMA

Current Price
₹140.
-0.2 (-0.14%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • 143.55
  • 50 Day
  • 145.48
  • 100 Day
  • 150.83
  • 200 Day
  • 157.72
  • 20 Day
  • 141.34
  • 50 Day
  • 144.36
  • 100 Day
  • 152.23
  • 200 Day
  • 159.45

Kilitch Drugs(I) Resistance and Support

PIVOT
₹141.57
Resistance
First Resistance 145.14
Second Resistance 150.07
Third Resistance 153.64
RSI 45.69
MFI 75.27
MACD Single Line 0.58
MACD 0.47
Support
First Resistance 136.64
Second Resistance 133.07
Third Resistance 128.14

Kilitch Drugs(I) Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 21,236 883,418 41.6
Week 14,748 834,589 56.59
1 Month 26,889 1,126,378 41.89
6 Month 11,191 650,879 58.16

Kilitch Drugs(I) Result Highlights

Kilitch Drugs(I) Synopsis

NSE-Medical-Diversified

Kilitch Drugs(I) is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 105.16 Cr. and Equity Capital is Rs. 15.58 Cr. for the Year ended 31/03/2022. Kilitch Drugs(I) Ltd. is a Public Limited Listed company incorporated on 12/05/1992 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24239MH1992PLC066718 and registration number is 066718.
Market Cap 217
Sales 107
Shares in Float 0.50
No of funds 2
Yield 0.51
Book Value 1.23
U/D Vol ratio 0.8
LTDebt / Equity
Alpha 0.01
Beta 0.79

Kilitch Drugs(I)

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 68.25%68.25%68.25%
Foreign Portfolio Investors
Financial Institutions/ Banks
Individual Investors 27.52%27.6%27.73%
Others 4.23%4.15%4.02%

Kilitch Drugs(I) Management

Name Designation
Mr. Mukund P Mehta Managing Director
Mr. Bhavin Mukund Mehta Whole Time Director
Mrs. Mira B Mehta Whole Time Director
Mr. Hemang Engineer Independent Director
Mr. Venkita Subramanian Rajan Independent Director
Prof. Vasudev Krishna Murti Independent Director

Kilitch Drugs(I) Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Kilitch Drugs(I) FAQs

What is Share Price of Kilitch Drugs(I) ?

Kilitch Drugs(I) share price is ₹140 As on 31 March, 2023 | 21:20

What is the Market Cap of Kilitch Drugs(I) ?

The Market Cap of Kilitch Drugs(I) is ₹218.2 Cr As on 31 March, 2023 | 21:20

What is the P/E ratio of Kilitch Drugs(I) ?

The P/E ratio of Kilitch Drugs(I) is 22.3 As on 31 March, 2023 | 21:20

What is the PB ratio of Kilitch Drugs(I) ?

The PB ratio of Kilitch Drugs(I) is 1.6 As on 31 March, 2023 | 21:20

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number